Synthesis and biological evaluation of truncated α-tubulin-binding pironetin analogues lacking alkyl pendants in the side chain or the dihydropyrone ring

被引:19
作者
Panos, Julian [1 ]
Diaz-Oltra, Santiago [1 ]
Sanchez-Peris, Maria [1 ]
Garcia-Pla, Jorge [1 ]
Murga, Juan [1 ]
Falomir, Eva [1 ]
Carda, Miguel [1 ]
Redondo-Horcajo, Mariano [2 ]
Fernando Diaz, J. [2 ]
Barasoain, Isabel [2 ]
Alberto Marco, J. [3 ]
机构
[1] Univ Jaume 1, Depart Q Inorgan & Organ, E-12071 Castellon de La Plana, Spain
[2] CSIC, Ctr Invest Biol, Madrid 28040, Spain
[3] Univ Valencia, Depart Q Organ, E-46100 Valencia, Spain
关键词
ENANTIOSELECTIVE TOTAL-SYNTHESIS; ASYMMETRIC ALDOL ADDITIONS; MICROTUBULE-ACTIVE AGENTS; N-ACYL OXAZOLIDINONES; CELL-CYCLE ARREST; EFFICIENT SYNTHESIS; CONFORMATION DESIGN; STABILIZING AGENTS; NATURAL-PRODUCTS; (-)-PIRONETIN;
D O I
10.1039/c3ob40854j
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The preparation of several new truncated analogues of the natural dihydropyrone pironetin is described. They differ from the natural product mainly in the suppression of some of the alkyl pendants in either the side chain or the dihydropyrone ring. Their cytotoxic activity and their interactions with tubulin have been investigated. It has been found that all analogues are cytotoxic towards two either sensitive or resistant tumoral cell lines with similar IC50 values in each case, thus strongly suggesting that, like natural pironetin, they also display a covalent mechanism of action. Their cytotoxicity is, however, lower than that of the parent compound. This indicates that all alkyl pendants are necessary for the full biological activity, with the ethyl group at C-4 seemingly being particularly relevant. Most likely, the alkyl groups cause a restriction in the conformational mobility of the molecule and reduce the number of available conformations. This makes it more probable that the molecule preferentially adopts a shape which fits better into the binding point in alpha-tubulin.
引用
收藏
页码:5809 / 5826
页数:18
相关论文
共 96 条
[11]   Asymmetric Total Synthesis of the Immunosuppressant (-)-Pironetin [J].
Bressy, Cyril ;
Vors, Jean-Pierre ;
Hillebrand, Stefan ;
Arseniyadis, Stellios ;
Cossy, Janine .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (52) :10137-10140
[12]   Microtubule interactions with chemically diverse stabilizing agents:: Thermodynamics of binding to the paclitaxel site predicts cytotoxicity [J].
Buey, RM ;
Barasoain, I ;
Jackson, E ;
Meyer, A ;
Giannakakou, P ;
Paterson, I ;
Mooberry, S ;
Andreu, JM ;
Díaz, JF .
CHEMISTRY & BIOLOGY, 2005, 12 (12) :1269-1279
[13]   Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites [J].
Buey, Ruben M. ;
Calvo, Enrique ;
Barasoain, Isabel ;
Pineda, Oriol ;
Edler, Michael C. ;
Matesanz, Ruth ;
Cerezo, Gemma ;
Vanderwal, Christopher D. ;
Day, Billy W. ;
Sorensen, Erik J. ;
Lopez, Juan Antonio ;
Andreu, Jose Manuel ;
Hamel, Ernest ;
Diaz, J. Fernando .
NATURE CHEMICAL BIOLOGY, 2007, 3 (02) :117-125
[14]   Microtubule targeting agents: from biophysics to proteomics [J].
Calligaris, D. ;
Verdier-Pinard, P. ;
Devred, F. ;
Villard, C. ;
Braguer, D. ;
Lafitte, Daniel .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (07) :1089-1104
[15]   Synthesis and Biological Evaluation As Microtubule-Active Agents of Several Tetrahydrofuran and Spiroacetal Derivatives [J].
Carda, M. ;
Murga, J. ;
Panos, J. ;
Angulo-Pachon, C. A. ;
Garcia-Pla, J. ;
Diaz-Oltra, S. ;
Marco, J. A. ;
Trigili, C. ;
Redondo-Horcajo, M. ;
Diaz, J. F. ;
Barasoain, I. .
CURRENT MEDICINAL CHEMISTRY, 2013, 20 (09) :1173-1182
[16]   Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors [J].
Chen, Jing ;
Liu, Tao ;
Dong, Xiaowu ;
Hu, Yongzhou .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (10) :1174-1190
[17]   Novel tubulin-interacting agents:: a tale of Taxus brevifolia and Catharanthus roseus-based drug discovery [J].
Chen, SH ;
Hong, J .
DRUGS OF THE FUTURE, 2006, 31 (02) :123-150
[18]   New microtubule-inhibiting anticancer agents [J].
Chen, Si-Meng ;
Meng, Ling-Hua ;
Ding, Jian .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (03) :329-343
[19]   Total synthesis of (-)-PA-48153C (pironetin) utilising L-quebrachitol as a chiral building block [J].
Chida, N ;
Yoshinaga, M ;
Tobe, T ;
Ogawa, S .
CHEMICAL COMMUNICATIONS, 1997, (11) :1043-1044
[20]   Physiochemical aspects of tubulin-interacting antimitotic drugs [J].
Correia, JJ ;
Lobert, S .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (13) :1213-1228